High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19

Diagnostic Molecular Pathology

Volumn 5, Issue 3, 1996, Pages 173-180

  Moscinski, Lynn C ^a   Trudeau, Walter L ^b   Fields, Karen K ^b   Elfenbein, Gerald J ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Breast cancer; Cytokeratin; Minimal residual disease; PCR

Indexed keywords

CYTOKERATIN;

ARTICLE; BREAST CARCINOMA; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

BREAST NEOPLASMS; CARCINOMA; DNA PRIMERS; FEMALE; HUMANS; KERATINS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0029811828     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199609000-00005     Document Type: Article

References (27)

1. Antman K, Corringham R, de Vries E, et al. Dose intensive therapy in breast cancer. Bone Marrow Transplant 1992; 10(suppl):67-73.
2. Bader BL, Jahn L, Franke WW. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 1988;47:300-19.
3. Coombs R. The staging of human breast cancer: physical staging techniques. In: Coombs R, Powles T, Ford H, et al., eds. Breast cancer management: the experience of the Combined Breast Cancer Clinic, St. Georges Hospital and Royal Marsden Hospital. San Diego, CA: Academic Press, 1981: 77-95.
4. Cote R, Rosen P, Lesser M, et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9:1749-56.
5. Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-82.
6. Dearnaley D, Ormerod M, Sloan J. Micrometastases in breast cancer: Long-term follow-up of the first patient cohort. Eur J Cancer 1991;27:236-9.
7. Diel I, Kaufmann M, Goerner R, et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992; 10:1534-9.
8. Ellis G, Ferguson M, Yamanaka E, et al. Monoclonal antibodies for the detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer 1989;63:2509-14.
9. Giai M, Natoli C, Sismondi P, et al. Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer. Anticancer Res 1990;10:119-22.
10. Hanukoglu I, Tanese N, Fuchs E. Complementary DNA sequence of a human cytoplasmic actin: interspecies divergence of 3′ non-coding regions. J Mol Biol 1983;163:673-8.
11. Harbeck N, Untch M, Pache L, Eirmann W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 1994;69:566-71.
12. Hillier L, Green P. OSP: a computer program for choosing PCR and DNA sequencing primers. PCR Methods Appl 1991;1:124-8.
13. Joshi SS, Novak DJ, Messbarger L, et al. Levels of detection of tumor cells in human bone marrow with or without prior culture. Bone Marrow Transplant 1990;6:179-83.
14. Kamby C, Guldhammer B, Vejborg I, et al. The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer 1987;49:513-8.
15. Mansi J, Easton D, Berger U, et al. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years follow-up. Eur J Cancer 1991;27:1552-5.
16. Mathieu M, Friedman S, Bosq J, et al. Immunohistochemi cal staining of bone marrow biopsies for detection of occult metastasis in breast cancer. Breast Cancer Res Treat 1990; 15:21-6.
17. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52: 4701-5.
18. Molina A, Colombatti M, Bonetti F, et al. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 1991;67:1033-6.
19. Moreno JG, Croce CM, Fischer R, et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992;52:6110-2.
20. Moscinski LC. The role of diagnostic molecular pathology in detection of minimal residual disease. Cancer Control 1995; 2:64-70.
21. Naito H, Kuzumaki N, Uchino J, et al. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J CanCer 1991;27:762-5.
22. Osborne M, Wong G, Asina S, et al. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 1991;51:2706-9.
23. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988;85: 2444-8.
24. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
25. Sharp JP, Vaughn WP, Kessinger A, et al. Significance of detection of tumor cells in hematopoietic stem cell harvests of patients with breast cancer. In Dicke KA, Armitage JO, Dicke-Evinger MJ, eds. Autologous bone marrow transplantation V. Omaha, NE: University of Nebraska Medical Center, 1990:385-91.
26. Smith I. Recurrent disease. In Harris J, Hellman S, Henderson IC, Kinne D, eds. Breast diseases. Philadelphia, PA: JB Lippincott, 1987:377.
27. Stasiak PC, Lane EB. Sequence of cDNA coding for human keratin 19. Nucleic Acids Res 1987;15:10058.